The invention relates to selective partial adenosine A1 receptor agonists of formula (I) and to the use thereof for the treatment and/or prevention of diseases and to the use thereof for producing medicaments for treating and/or preventing diseases, preferably acute and/or chronic renal diseases (primary disease and secondary disease) with or without accompanying acute and/or heart diseases.La presente invención se refiere a agonistas del receptor A1 de adenosina parciales selectivos de la fórmula (I) y su uso para tratar y/o prevenir enfermedades y con su uso para preparar medicamentos para tratar y/o prevenir enfermedades, preferiblemente para tratar y/o prevenir trastornos renales agudos y/o crónicos (trastorno primario y trastorno secundario) con y sin trastornos cardiacos agudos y/o crónicos concomitantes.
